|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
11/02/2023 |
$18.96 |
$18.98 |
$18.93 |
$18.98 |
2.10M | 11/03/2023 |
$18.97 |
$18.99 |
$18.95 |
$18.98 |
1.03M | 11/06/2023 |
$18.97 |
$19.02 |
$18.96 |
$18.96 |
3.61M | 11/07/2023 |
$19.00 |
$19.01 |
$18.98 |
$19.00 |
3.96M | 11/08/2023 |
$19.00 |
$19.00 |
$19.00 |
$19.00 |
0 |
|
Intercept Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases utilizing its proprietary bile acid chemistry. Co.'s marketed product, Ocaliva® (obeticholic acid or OCA), is an farnesoid X receptor agonist approved in the U.S., the European Union and several other jurisdictions for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA or as monotherapy in adults unable to tolerate UDCA. In addition, Co. is developing OCA for additional indications, including nonalcoholic steatohepatitis. | |
|
Intercept Pharmaceuticals (ICPT) has the following price history information. Looking back at ICPT historical stock prices for the last five trading days, on November 02, 2023, ICPT opened at $18.96, traded as high as $18.98 and as low as $18.93, and closed at $18.98. Trading volume was a total of 2.10M shares. On November 03, 2023, ICPT opened at $18.97, traded as high as $18.99 and as low as $18.95, and closed at $18.98. Trading volume was a total of 1.03M shares. On November 06, 2023, ICPT opened at $18.97, traded as high as $19.02 and as low as $18.96, and closed at $18.96. Trading volume was a total of 3.61M shares. On November 07, 2023, ICPT opened at $19.00, traded as high as $19.01 and as low as $18.98, and closed at $19.00. Trading volume was a total of 3.96M shares. On November 08, 2023, ICPT opened at $19.00, traded as high as $19.00 and as low as $19.00, and closed at $19.00. Trading volume was a total of 0 shares.
ICPT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Intercept Pharmaceuticals shares, starting with a $10,000 purchase of ICPT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
11/08/2023 |
|
Start price/share: |
$329.79 |
|
End price/share: |
$19.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-94.24% |
|
Average Annual Total Return: |
-25.69% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$575.82 |
|
Years: |
9.61 |
|
|
|
Date |
Close |
11/02/2023 | $18.98 | 11/03/2023 | $18.98 | 11/06/2023 | $18.96 | 11/07/2023 | $19.00 | 11/08/2023 | $19.00 |
|
|